Drug Development Infrastructure Supporting the Research Community in Medication Repurposing for Substance Use Disorders
Forecast: not open for applications yet. Dates are the funder's estimate. Save a search and Brieflist marks it when it opens (Grants Pro e-mails you), or get the free weekly digest:
This is a forecast: the funder has announced the grant but applications are not open yet. Dates may change.
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by supporting a dynamic and adaptable drug-development infrastructure to accelerate medication repurposing and repositioning for substance use disorders (SUDs).
Read the official page on Grants.gov ↗ Get new grants like this
- Funder
- National Institutes of Health (Department of Health and Human Services)
- Where
- 🇺🇸 United States
- Status
- Forecast · opens about 25 Feb 2027 · deadline about 1 Jun 2027
- Funding
- $2.5m in total
- Expected awards
- 1
- Who can apply
- Most organisations
- Topics
- Health
- Opportunity number
- RFA-DA-28-009
- Instrument
- Cooperative agreement
About this grant
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by supporting a dynamic and adaptable drug-development infrastructure to accelerate medication repurposing and repositioning for substance use disorders (SUDs). The infrastructure will serve academic and biotech investigators by providing coordinated scientific expertise, shared resources, and tailored support across the drug-development continuum. Capabilities may include in silico discovery, target and assay validation, preclinical and translational development, pharmacology, toxicology, clinical protocol development, patient engagement, Target Product Profile development, Freedom-to-Operate and intellectual property strategy, regulatory guidance, and market-access planning. The infrastructure will also engage the research community through outreach, proposal solicitation, and a structured project-selection process, supporting user-led projects across a broad range of SUD indications. The goal is to help promising repurposed and repositioned therapeutics progress toward clinical development and potential market access. Grant authorities that allow the NIDA to forecast this opportunity are as follows: 42 U.S.C. 241 and 284.
Eligibility
Small businesses; Special district governments; For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; City or township governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal governments (Federally recognized); State governments; Public and State controlled institutions of higher education; Private institutions of higher education; County governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments). Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Applying for grants? Grants Pro e-mails you every morning with the new grants and opened forecasts that match your saved searches, and adds deadline reminders in your calendar, a private RSS feed and CSV export. Try it free for 7 days, then $9/month, cancel any time. See what Pro does →
More from this funder: 354 open opportunities from National Institutes of Health (NIH).
Applying? Read how to write a winning grant proposal.
Data from Grants.gov, US federal government (public domain). Last checked 19 Nov 2026. Always read the official page before applying: it has the full conditions, documents and how to apply.